PRE-MARKET Updates

PRE-MARKET MOVERS 1. NKTR:  $NKTR Nektar takes the spotlight at SITC touting some promising early data for hard-to-treat cancers 2. HAS, MAT:  $MAT Hasbro $HAS Sets Its Sights on Mattel - WSJ 3. JNJ, ZYME:  $ZYME Zymeworks inks deal with Janssen Biotech $JNJ to...

PRE-MARKET MOVERS 1. OTIC:  $OTIC Otonomy Says AVERTS-2 Phase 3 Trial of OTIVIDEX Achieved Primary Endpoint - SI 2. SAGE:  $SAGE Sage Therapeutics drug reduces postpartum depression in two late-stage clinical trials - STAT 3. ROKU:  $ROKU Roku shares skyrocket as...

PRE-MARKET MOVERS 1. AVGR:  $AVGR Avinger Receives 510 Clearance for Design Modifications of Pantheris - SI 2. ARQL:  $ARQL ArQule nabs Rare Pediatric Disease Designation for miransertib for Proteus syndrome - SA 3. BGS:  $BGS B&G Foods Reports Financial Results...

PRE-MARKET MOVERS 1. DYN, VST:  $DYN $VST and DYN to combine 2. AAAP, NVS:  $AAAP to be acquired by $NVS 3. STRA:  $STRA Strayer and Capella agree all stock merger 4. CAA, LEN:  $LEN $LEN and $CAA to merge 5. MRK:  $MRK weak after withdrawing European Keytruda app...

PRE-MARKET MOVERS 1. AIMT:  $AIMT DBV shares are crushed — while rival Aimmune soars — after PhIII flop for peanut allergy med 2. PETS:  $PETS PetMed's stock soars after profit, revenue beat by wide margin - MW 3. AGEN, GSK:  $AGEN Agenus Granted FDA Approval for...

PRE-MARKET MOVERS 1. CATB:  $CATB After a recent failure, Catabasis uses open-label data for phase 3 push - FierceBiotech 2. CATB:  $CATB Catabasis conjures a stock gain from a failed Duchenne study, assisted by a frothy biotech market 3. AMGN, CTMX:  $CTMX Amgen...